N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms

被引:64
作者
Chen, Lin [1 ]
Gao, Yang [1 ]
Xu, Simiao [2 ]
Yuan, Jinxiong [1 ]
Wang, Min [1 ]
Li, Tianyu [3 ]
Gong, Jun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary Pancreat Surg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Branch Natl Clin Res,Ctr Metab Dis,Div Endocrinol, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Trauma Ctr,Dept Emergency & Traumat Surg, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
M6A; YTHDF; biological process; cancer; clinical applications; MESSENGER-RNA DEGRADATION; LUNG-CANCER PROGRESSION; NF-KAPPA-B; NUCLEAR-RNA; DOMAIN FAMILY; STEM-CELLS; TRANSLATIONAL CONTROL; M(6)A METHYLATION; POOR-PROGNOSIS; N-6-METHYLADENOSINE;
D O I
10.3389/fimmu.2023.1162607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As the most abundant and conserved internal modification in eukaryote RNAs, N6-methyladenosine (m(6)A) is involved in a wide range of physiological and pathological processes. The YT521-B homology (YTH) domain-containing family proteins (YTHDFs), including YTHDF1, YTHDF2, and YTHDF3, are a class of cytoplasmic m(6)A-binding proteins defined by the vertebrate YTH domain, and exert extensive functions in regulating RNA destiny. Distinct expression patterns of the YTHDF family in specific cell types or developmental stages result in prominent differences in multiple biological processes, such as embryonic development, stem cell fate, fat metabolism, neuromodulation, cardiovascular effect, infection, immunity, and tumorigenesis. The YTHDF family mediates tumor proliferation, metastasis, metabolism, drug resistance, and immunity, and possesses the potential of predictive and therapeutic biomarkers. Here, we mainly summary the structures, roles, and mechanisms of the YTHDF family in physiological and pathological processes, especially in multiple cancers, as well as their current limitations and future considerations. This will provide novel angles for deciphering m(6)A regulation in a biological system.
引用
收藏
页数:24
相关论文
共 294 条
[11]   YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NE-κB and promote the malignant progression of glioma [J].
Chai, Rui-Chao ;
Chang, Yu-Zhou ;
Chang, Xin ;
Pang, Bo ;
An, Song Yuan ;
Zhang, Ke-Nan ;
Chang, Yuan-Hao ;
Jiang, Tao ;
Wang, Yong-Zhi .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[12]   YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis [J].
Chang, Guoqiang ;
Shi, Lei ;
Ye, Youqiong ;
Shi, Hailing ;
Zeng, Lixian ;
Tiwary, Shweta ;
Huse, Jason T. ;
Huo, Lei ;
Ma, Li ;
Ma, Yongjie ;
Zhang, Sicong ;
Zhu, Jianwei ;
Xie, Victoria ;
Li, Peng ;
Han, Leng ;
He, Chuan ;
Huang, Suyun .
CANCER CELL, 2020, 38 (06) :857-+
[13]   METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma [J].
Chang, Yu-Zhou ;
Chai, Rui-Chao ;
Pang, Bo ;
Chang, Xin ;
An, Song Yuan ;
Zhang, Ke-Nan ;
Jiang, Tao ;
Wang, Yong-Zhi .
CANCER LETTERS, 2021, 511 :36-46
[14]   N6-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis [J].
Chen, Feng ;
Chen, Zhuojia ;
Guan, Tao ;
Zhou, Yan ;
Ge, Lichen ;
Zhang, Haisheng ;
Wu, Yingmin ;
Jiang, Guan-Min ;
He, Weiling ;
Li, Jiexin ;
Wang, Hongsheng .
CANCER RESEARCH, 2021, 81 (11) :2847-2860
[15]   YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner [J].
Chen, Hengyu ;
Yu, Yuanhang ;
Yang, Ming ;
Huang, Haohao ;
Ma, Shenghui ;
Hu, Jin ;
Xi, Zihan ;
Guo, Hui ;
Yao, Guojie ;
Yang, Liu ;
Huang, Xiaoqing ;
Zhang, Feng ;
Tan, Guanghong ;
Wu, Huangfu ;
Zheng, Wuping ;
Li, Lei .
CELL AND BIOSCIENCE, 2022, 12 (01)
[16]   YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells [J].
Chen, Jixiang ;
Sun, Yaocheng ;
Xu, Xiao ;
Wang, Dawei ;
He, Junbo ;
Zhou, Hailang ;
Lu, Ying ;
Zeng, Jian ;
Du, Fengyi ;
Gong, Aihua ;
Xu, Min .
CELL CYCLE, 2017, 16 (23) :2259-2271
[17]   RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2 [J].
Chen, Mengnuo ;
Wei, Lai ;
Law, Cheuk-Ting ;
Tsang, Felice Ho-Ching ;
Shen, Jialing ;
Cheng, Carol Lai-Hung ;
Tsang, Long-Hin ;
Ho, Daniel Wai-Hung ;
Chiu, David Kung-Chun ;
Lee, Joyce Man-Fong ;
Wong, Carmen Chak-Lui ;
Ng, Irene Oi-Lin ;
Wong, Chun-Ming .
HEPATOLOGY, 2018, 67 (06) :2254-2270
[18]   Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism [J].
Chen, Ping ;
Liu, Xi-qiao ;
Lin, Xiang ;
Gao, Li-ying ;
Zhang, Shuo ;
Huang, Xuan .
MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 :228-239
[19]   The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner [J].
Chen, Xiao-Yu ;
Liang, Rui ;
Yi, You-Cai ;
Fan, Hui-Ning ;
Chen, Ming ;
Zhang, Jing ;
Zhu, Jin-Shui .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[20]   METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer [J].
Chen, Xiaoxiang ;
Xu, Mu ;
Xu, Xueni ;
Zeng, Kaixuan ;
Liu, Xiangxiang ;
Pan, Bei ;
Li, Chenmeng ;
Sun, Li ;
Qin, Jian ;
Xu, Tao ;
He, Bangshun ;
Pan, Yuqin ;
Sun, Huilin ;
Wang, Shukui .
MOLECULAR CANCER, 2020, 19 (01)